Our Latest News
[PRESS RELEASE] Biofortis strengthens its service offerings with the acquisition of analyze & realize
We are excited to announce that Biofortis, a leading European premium CRO has completed the acquisition of analyze...
[EVENT] Biofortis will be present at NUTREVENT – SILVER SPONSOR
October 17th & 18th 2023in Rennes, FRANCECome and meet us at NutrEvent in Rennes, France.As the European leading...
[NEWS] ACCELERATE YOUR ASSAYS
In a continuous improvement of our performance and analytical capabilities that's complements Biofortis Central lab,...
[EVENT] Biofortis will be present at Outsourcing In Clinical Trials Europe 2022
May 4th and 5th 2022Come and meet us at the Outsourcing In Clinical Trials (OCT) Europe 2022 in Barcelona, Spain. This event will provide participants with practical take-away messages and...
[EVENT] – Biofortis will be present at PHARMABIOTICS 2022
For this 2022 edition, Biofortis will be present during the Pharmabiotic Research Institute (PRI)'s annual conference in Lyon, France, 20/21 April 2022. Our CSO, Françoise Le Vacon will lead a...
[EVENT] – Biofortis will be present at Vitafoods Europe 2022
For this 2022 edition, Vitafoods Europe 2022 will take a hybrid format: we will be present both virtual and in person, in Geneva, Switzerland. Vitafoods Europe is one of the most important events in...
Innovation Sponsor – MDD 2022
6th Microbiome Movement Drug Development Europe 2022 January, 26th-27th Come and e-meet us at the 6th Microbiome Movement – Drug Development Europe 2022 Congress. This event is part of the major...
[EVENT] – Biofortis will exhibit at VITAFOODS 2021
For this 2021 edition, Vitafoods Europe 2021 will take a hybrid format: we will be present both virtual and in person, in Geneva, Switzerland. It represents one of the most important events in the...
Biofortis continues its development alongside Institut Mérieux
Benoît Fouchaq, CEO of Biofortis SASAs part of a new strategy, Mérieux NutriSciences has decided to sell the majority of Biofortis’ shares to its Management, through a “Management Buy-Out” project....